|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
ES2249761T3
(es)
|
1993-06-24 |
2006-04-01 |
Advec Inc. |
Vectores de adenovirus para terapia genica.
|
|
EP1637608B1
(en)
|
1993-10-25 |
2009-07-22 |
CANJI, Inc. |
Recombinant adenoviral vector and methods of use
|
|
PT733103E
(pt)
|
1993-11-09 |
2004-07-30 |
Targeted Genetics Corp |
Criacao de elevados titulos de vectores de aav recombinantes
|
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
|
CA2187626C
(en)
|
1994-04-13 |
2009-11-03 |
Michael G. Kaplitt |
Aav-mediated delivery of dna to cells of the nervous system
|
|
US5986054A
(en)
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
AU732508B2
(en)
|
1996-01-26 |
2001-04-26 |
Governing Council Of The University Of Toronto, The |
Nucleic acids and proteins related to Alzheimer's disease, and uses therefor
|
|
AR020107A1
(es)
*
|
1998-07-09 |
2002-04-10 |
Boehringer Ingelheim Pharma |
Metodo para identificar una sustancia capaz de reducir o eliminar la actividad de la presenilinasa, las sustancias identificables con dicho metodo, el usode estas ultimas en la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y las composiciones farmaceuticas que
|
|
AU4992099A
(en)
*
|
1998-07-16 |
2000-02-07 |
Incyte Pharmaceuticals, Inc. |
Human presenilin-associated protein
|
|
US6979537B2
(en)
|
2000-01-10 |
2005-12-27 |
Scios, Inc. |
Methods for identifying inhibitors of neuronal degeneration
|
|
US6686449B2
(en)
|
2000-06-30 |
2004-02-03 |
Pharmacia & Upjohn Company |
Mutant presenilin 1 polypeptides
|
|
WO2004016733A2
(en)
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
|
US7271313B2
(en)
|
2003-04-09 |
2007-09-18 |
The Brigham And Women's Hospital, Inc. |
Presenilin-deficient mouse model of age-dependent neurodegeneration and cognitive loss
|
|
CA2528963A1
(en)
|
2003-06-27 |
2005-01-13 |
Sirna Therapeutics, Inc. |
Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina)
|
|
WO2005037226A2
(en)
|
2003-10-17 |
2005-04-28 |
Georgia Tech Research Corporation |
Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders
|
|
PL1675956T3
(pl)
|
2003-10-21 |
2011-06-30 |
Merck Serono Sa |
Minimalna sekwencja DNA działająca jako insulator chromatyny i jej zastosowanie do wyrażania białek
|
|
US7498316B2
(en)
|
2004-04-06 |
2009-03-03 |
University Of Massachusetts |
Methods and compositions for treating gain-of-function disorders using RNA interference
|
|
CA2566519C
(en)
|
2004-05-14 |
2020-04-21 |
Rosetta Genomics Ltd. |
Micrornas and uses thereof
|
|
JP2008500039A
(ja)
|
2004-05-26 |
2008-01-10 |
ロゼッタ ジノミクス リミテッド |
ウイルスｍｉＲＮＡおよびウイルス関連ｍｉＲＮＡならびにその使用
|
|
US8129334B2
(en)
|
2006-03-31 |
2012-03-06 |
The Regents Of The University Of California |
Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
WO2009042727A1
(en)
|
2007-09-24 |
2009-04-02 |
The Johns Hopkins University |
Immediate early gene arc interacts with endocytic machinery and regulates the trafficking and function of presenilin
|
|
WO2011054976A2
(en)
|
2009-11-09 |
2011-05-12 |
Genepod Therapeutics Ab |
Novel viral vector construct for neuron specific optimized continuous dopa synthesis in vivo
|
|
WO2012075040A2
(en)
|
2010-11-30 |
2012-06-07 |
Shire Human Genetic Therapies, Inc. |
mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
|
|
CN103816540B
(zh)
*
|
2012-11-16 |
2018-01-02 |
中国科学院上海生命科学研究院 |
降低β‑抑制蛋白1与APH‑1蛋白的结合的物质在制备防治神经退行性疾病药物中的应用
|
|
CN105377039A
(zh)
|
2013-05-15 |
2016-03-02 |
明尼苏达大学董事会 |
腺相关病毒介导的基因向中枢神经系统转移
|
|
HK1222673A1
(zh)
*
|
2013-07-12 |
2017-07-07 |
The Children's Hospital Of Philadelphia |
Aav载体和用於抗aav(腺相关病毒)中和抗体的检测
|
|
GB201404470D0
(en)
|
2014-03-13 |
2014-04-30 |
Ucl Business Plc |
Therapeutic methods and materials
|
|
GB201413665D0
(en)
*
|
2014-07-03 |
2014-09-17 |
Transimmune Ag And Yale University |
Method for obtaining globally activated monocytes
|
|
US10350245B2
(en)
|
2015-01-21 |
2019-07-16 |
Fred Hutchinson Cancer Research Center |
Point-of-care and/or portable platform for gene therapy
|
|
JP2018510160A
(ja)
*
|
2015-03-20 |
2018-04-12 |
ブルーバード バイオ， インコーポレイテッド |
ベクター製剤
|
|
WO2016209654A1
(en)
*
|
2015-06-22 |
2016-12-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and devices for imaging and/or optogenetic control of light-responsive neurons
|
|
EP3452101A2
(en)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Rna encoding a therapeutic protein
|
|
EP4316588A3
(en)
|
2016-05-27 |
2024-05-15 |
Transcriptx, Inc. |
Treatment of primary ciliary dyskinesia with synthetic messenger rna
|
|
WO2018045022A1
(en)
|
2016-08-30 |
2018-03-08 |
University Of South Florida |
Adipose derived stem cell exosomes and uses thereof
|
|
CA3050264A1
(en)
|
2017-01-24 |
2018-08-02 |
Fred Hutchinson Cancer Research Center |
Systems and methods for hematopoietic cell expansion utilizing hydrogels
|
|
US11713470B2
(en)
|
2017-03-20 |
2023-08-01 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Targeted gene therapies for pain and other neuro-related disorders
|
|
ES3039647T3
(en)
|
2017-05-31 |
2025-10-23 |
Arcturus Therapeutics Inc |
Synthesis and structure of high potency rna therapeutics
|
|
JP7221275B2
(ja)
|
2017-08-03 |
2023-02-13 |
ボイジャー セラピューティクス インコーポレイテッド |
Ａａｖを送達するための組成物および方法
|
|
EP3796980A4
(en)
|
2018-05-22 |
2022-03-23 |
The Brigham & Women's Hospital, Inc. |
NEW THERAPY FOR ALZHEIMER'S DISEASE
|
|
WO2020242892A1
(en)
|
2019-05-24 |
2020-12-03 |
The Brigham And Women's Hospital, Inc. |
Gene therapy for alzheimer's disease
|
|
IL293285A
(en)
|
2019-11-29 |
2022-07-01 |
Paros Bio Inc |
Gene therapy for neurodegenerative disorders
|
|
US20230136245A1
(en)
|
2020-01-31 |
2023-05-04 |
Paros Bio, Inc. |
Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacement
|